High dose mitoxantrone and melphalan followed by autologous stem cell transplantation for lymphoid malignancies

被引：1
|
作者：
Chan, GW [1 ]
Sprague, KA [1 ]
Klein, AK [1 ]
Klingemann, HG [1 ]
机构：
[1] Tufts New England Med Ctr, Boston, MA USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2006年 / 12卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2005.11.299
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
276
引用
收藏
页码：98 / 98
页数：1
相关论文
共 50 条
  • [41] HIGH -DOSE CHEMOTHERAPY WITH BeEAM PROTOCOL (BENDAMUSTINE, ETOPOSIDE, ARACYTIN, MELPHALAN) FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANTATION IN 30 PATIENTS WITH HODGKIN LYMPHOMA
    Akhrouf, Sabrina
    Abderahim, Imene
    Amer, Nacera Ait
    Tensaout, Farida
    Belhadri, Fatiha
    Moussaoui, Hanane
    Belhadj, Rachida
    Mehdid, Farih
    Benakli, Malek
    Hamladji, Rose-Marie
    Nacer, Redhouane Ahmed
    BONE MARROW TRANSPLANTATION, 2018, 53 : 609 - 610
  • [42] High Dose Intravenous Busulfan and Melphalan Followed By Bortezomib (BuMelVel) As Conditioning With Autologous Stem Cell Transplantation (ASCT) For Patients With Multiple Myeloma (MM)
    Sterrenberg, Danielle
    Stiff, Patrick J.
    Parthasarathy, Mala
    Go, Aileen
    Smith, Scott E.
    Rodriguez, Tulio E.
    BLOOD, 2013, 122 (21)
  • [43] High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous stem cell transplantation in patients with advanced breast cancer: a retrospective evaluation
    T Demirer
    V A Uysal
    M Aylı
    Y Genc
    O Ilhan
    H Koc
    M Daglı
    M Arat
    N Gunel
    T Fen
    S Dincer
    N Ustael
    M Yildiz
    T Ustun
    E Seyrek
    G Ozet
    O Muftuoglu
    H Akan
    Bone Marrow Transplantation, 2003, 31 : 755 - 761
  • [44] Cardiac transplant followed by high-dose melphalan and autologous stem cell transplantation (ASCT) for patients with AL amyloidosis and severe heart failure
    Dey, Bimalangshu R.
    Spitzer, Thomas R.
    MacGillivray, Thomas E.
    Chung, Stephen S.
    Dec, G. W.
    Seldin, David C.
    McAfee, Steven L.
    Ballen, Karen
    Attar, Eyal
    Skinner, Martha
    Madsen, Joren C.
    Semigran, Marc J.
    BLOOD, 2007, 110 (11) : 225A - 225A
  • [45] An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis
    V Sanchorawala
    DG Wright
    DC Seldin
    LM Dember
    K Finn
    RH Falk
    J Berk
    K Quillen
    M Skinner
    Bone Marrow Transplantation, 2001, 28 : 637 - 642
  • [46] Role of high-dose melphalan and autologous peripheral blood stem cell transplantation in AL amyloidosis
    Sanchorawala, Vaishali
    AMERICAN JOURNAL OF BLOOD RESEARCH, 2012, 2 (01): : 9 - 17
  • [47] High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myeloma
    Alexandra Gomez-Arteaga
    Tomer M. Mark
    Danielle Guarneri
    Paul J. Christos
    Usama Gergis
    June D. Greenberg
    Jingmei Hsu
    Sebastian A. Mayer
    Ruben Niesvizky
    Roger N. Pearse
    Adrienne A. Phillips
    Adriana Rossi
    Morton Coleman
    Koen van Besien
    Tsiporah B. Shore
    Bone Marrow Transplantation, 2019, 54 : 2027 - 2038
  • [48] Brachial plexopathy following high-dose melphalan and autologous peripheral blood stem cell transplantation
    Parrish, C.
    Ming, A.
    Patmore, R.
    Shields, M.
    Allsup, D.
    BONE MARROW TRANSPLANTATION, 2010, 45 (05) : 951 - 952
  • [49] Brachial plexopathy following high-dose melphalan and autologous peripheral blood stem cell transplantation
    C Parrish
    A Ming
    R Patmore
    M Shields
    D Allsup
    Bone Marrow Transplantation, 2010, 45 : 951 - 952
  • [50] Role of palifermin for autologous hematopoietic stem cell transplantation after conditioning with high-dose melphalan
    Verraes, Kristof
    Delforge, Michel
    ACTA CLINICA BELGICA, 2010, 65 (06): : 457 - 457
12345